Journal of Virus Eradication最新文献

{"title":"Vaccination against COVID-19 among healthcare workers as a cocoon strategy for people living with HIV","authors":"Agata Skrzat-Klapaczyńska ,&nbsp;Justyna Kowalska ,&nbsp;Filip Fijołek ,&nbsp;Marcin Paciorek ,&nbsp;Carlo Bieńkowski ,&nbsp;Dominika Krogulec ,&nbsp;Andrzej Horban","doi":"10.1016/j.jve.2024.100377","DOIUrl":"10.1016/j.jve.2024.100377","url":null,"abstract":"<div><h3>Introduction</h3><p>Healthcare professionals working in infectious disease units are often engaged in the care of patients with HIV infection. A cocoon vaccination strategy may protect those who are immunocompromised from a severe course of COVID-19.</p></div><div><h3>Methods</h3><p>The research was conducted between January 2021 and June 2022. The study participants were 450 healthcare workers (HCWs) from the Hospital for Infectious Diseases in Warsaw who were vaccinated against COVID-19 with the BNT162b2 mRNA vaccine (Pfizer-BioNTech) –, thefirst available type of vaccine in Poland. Sera were collected according to the schedule of the study. Statistical analyses were performed with non-parametric tests: Wilcoxon's test was used to compare dependent numerical variables, and Fisher's exact test and the Chi-squared test to compare categorical variables. A <em>p</em> value of &lt;0.05 was considered statistically significant.</p></div><div><h3>Results</h3><p>Among the 450 HCWs working in the Hospital for Infectious Diseases in Warsaw 412 (91,5 %) were vaccinated against COVID-19. In total 170 (41,3 %) vaccinated HCWs were included in the final analysis. Their median age was 51 years [interquartile range (IQR): 41–60 years] and median body mass index (BMI) was 25.10 [IQR: 22.68–29.03]. Most of the cohort consisted of women (n = 137, 80.59 %), with the majority working directly with patients (n = 137, 73.21 %). It was found that as early as 14 days after the second dose of the vaccine, 100 % of the study participants achieved a positive result for SARS CoV-2 S-RBD antibodies. There were 168 subjects who had had a COVID-19 diagnosis before entering study and after vaccination 65 HCWs was diagnosed with COVID-19.</p></div><div><h3>Conclusions</h3><p>Due to the fact that people living with HIV with severe immunodeficiency may have an incomplete immune response to COVID vaccination and be at risk of a severe course of the disease, the cocoon strategy of vaccinating medical personnel may be beneficial for these patients.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 2","pages":"Article 100377"},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000141/pdfft?md5=8d5f3d22dd455405e92483c07be9374d&pid=1-s2.0-S2055664024000141-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141414827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From awareness to action: Unveiling knowledge, attitudes and testing strategies to enhance human papillomavirus vaccination uptake in Jordan","authors":"Ahmad Al-leimon ,&nbsp;Obada Al-leimon ,&nbsp;Bayan Abdulhaq ,&nbsp;Fadi Al-salieby ,&nbsp;Abdul-Raheem Jaber ,&nbsp;Mohammed Saadeh ,&nbsp;Abdel Rahman Jaber ,&nbsp;Omer Aziziye ,&nbsp;Latefa Ali Dardas","doi":"10.1016/j.jve.2024.100380","DOIUrl":"10.1016/j.jve.2024.100380","url":null,"abstract":"<div><h3>Purpose</h3><p>Vaccination against HPV plays a crucial role in preventing cervical cancer and related health issues. This study aimed to (1) assess knowledge, awareness, intentions, and attitudes regarding HPV and vaccination among Jordanian parents, and (2) evaluate the efficacy of two intervention strategies in promoting knowledge, awareness, and attitudes towards HPV vaccinations.</p></div><div><h3>Methods</h3><p>In study one, a web-based survey was used to collect data from Jordanian parents. In study two, participants were allocated into three groups: video-based intervention, lecture-based intervention, and a control group. Pre-post tests were conducted to evaluate the efficacy of the intervention strategies in promoting knowledge, awareness, and attitudes toward HPV vaccination among Jordanian parents.</p></div><div><h3>Results</h3><p>A total of 572 participants took part in the survey. Knowledge levels about HPV and its vaccine were generally low. Intentions regarding HPV vaccination were uncertain for the majority of participants, with 92 % reported as not receiving any guidance from medical professionals about administering the HPV vaccine to themselves or their children. Only 22 % agreed that their children might get infected with HPV at any time in their lives. The pilot randomized clinical trial revealed an improvement in knowledge, awareness, and attitudes towards HPV vaccination in both intervention groups compared to the control group with large effect sizes (eta squared between 0.29 and 0.68).</p></div><div><h3>Conclusions</h3><p>Findings highlight the need for increased knowledge and awareness regarding HPV and vaccination. It also supported the potential effectiveness of basic educational efforts in significantly improving knowledge, awareness, and attitudes towards the HPV vaccine.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 2","pages":"Article 100380"},"PeriodicalIF":3.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000177/pdfft?md5=48f64338fb12913cad940d60abea6e51&pid=1-s2.0-S2055664024000177-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141397091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial","authors":"Jasmini Alagaratnam ,&nbsp;Wolfgang Stöhr ,&nbsp;Elizabeth Hamlyn ,&nbsp;Kholoud Porter ,&nbsp;Jamie Toombs ,&nbsp;Amanda Heslegrave ,&nbsp;Henrik Zetterberg ,&nbsp;Magnus Gisslén ,&nbsp;Jonathan Underwood ,&nbsp;Mauro Schechter ,&nbsp;Pontiano Kaleebu ,&nbsp;Giuseppe Tambussi ,&nbsp;Sabine Kinloch ,&nbsp;Jose M. Miro ,&nbsp;Anthony D. Kelleher ,&nbsp;Abdel Babiker ,&nbsp;John Frater ,&nbsp;Alan Winston ,&nbsp;Sarah Fidler ,&nbsp;The SPARTAC Trial Investigators","doi":"10.1016/j.jve.2024.100381","DOIUrl":"https://doi.org/10.1016/j.jve.2024.100381","url":null,"abstract":"<div><h3>Objective</h3><p>Antiretroviral therapy (ART)-conferred suppression of HIV replication limits neuronal injury and inflammation. ART interruption tests efficacy in HIV cure trials and viral rebound after ART interruption may induce neuronal injury. We investigated the impact of protocol-defined ART interruption, commenced during primary HIV-1 infection (PHI) on a biomarker of neuro-axonal injury (neurofilament light protein (NfL)), and its associations with inflammation (D-dimer and interleukin-6 (IL-6)) and HIV-1 reservoir size (total HIV-1 DNA).</p></div><div><h3>Design</h3><p>Retrospective study measuring plasma NfL in 83 participants enrolled in SPARTAC randomised to receive 48-weeks ART initiated during PHI, followed by ART interruption.</p></div><div><h3>Methods</h3><p>NfL (Simoa immunoassay, Quanterix™) was measured before ART, after 48 weeks on ART, and 12 weeks after stopping ART. Plasma D-dimer and IL-6, and total HIV-1 DNA in peripheral CD4⁺ T-cells results were available in a subset of participants. Longitudinal NfL changes were assessed using mixed models, and associations with clinical and laboratory parameters using linear regression.</p></div><div><h3>Results</h3><p>NfL decreased following 48-weeks ART (geometric mean 6.9 to 5.8 pg/mL, p = 0.006) with no further significant change up to 12-weeks post-stopping ART despite viral rebound in the majority of participants (median 1.7 to 3.9 plasma HIV-1 RNA log₁₀ copies/mL). Higher baseline NfL was independently associated with higher plasma HIV-1 RNA (p = 0.020) and older age (p = 0.002). While NfL was positively associated with D-dimer (n = 48; p = 0.002), there was no significant association with IL-6 (n = 48) or total HIV-1 DNA (n = 51).</p></div><div><h3>Conclusions</h3><p>Using plasma NfL as a surrogate marker, a decrease in neuro-axonal injury was observed in a cohort of participants following ART initiation during PHI, with no evidence of neuro-axonal injury rebound following ART interruption for up to 12 weeks, despite viral rebound in the majority of participants.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 2","pages":"Article 100381"},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000189/pdfft?md5=e27b2f871c80de05181d324e7dfff871&pid=1-s2.0-S2055664024000189-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141322408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Community dialogue to enhance understanding of beliefs, behaviours and barriers to care for people living with liver disease and HBV infection in KwaZulu Natal, South Africa","authors":"Busangani Ngwenya ,&nbsp;Motswedi Anderson ,&nbsp;Nondumiso Mpanza ,&nbsp;Welcome Mbokazi ,&nbsp;Luthando Zuma ,&nbsp;Thandeka Khoza ,&nbsp;Gloria Sukali ,&nbsp;Elizabeth Waddilove ,&nbsp;Marion Delphin ,&nbsp;Collins Iwuji ,&nbsp;Ngcebo Mhlongo ,&nbsp;Nomathamsanqa Majozi ,&nbsp;Janet Seeley ,&nbsp;Janine Upton ,&nbsp;Guy Harling ,&nbsp;Philippa C. Matthews ,&nbsp;Anita Edwards","doi":"10.1016/j.jve.2024.100378","DOIUrl":"10.1016/j.jve.2024.100378","url":null,"abstract":"<div><h3>Introduction</h3><p>The World Health Organisation (WHO) has set targets for the elimination of Hepatitis B virus (HBV), which include preventing new infections and reducing deaths. We explored beliefs, behaviours and barriers to diagnosis, prevention and treatment for people living with HBV infection (PLWHB) and those with liver disease in a rural South African population in KwaZulu-Natal, to gather information to inform research and support the development of improved clinical and public health services.</p></div><div><h3>Methods</h3><p>Using an interdisciplinary approach (combining public engagement, social science, clinical and laboratory team members) we conducted a community dialogue with members of the Africa Health Research Institute (AHRI) Community Advisory Board (CAB). Notes from the discussions were used to write up an account from which themes were identified during a team debrief session for data analysis.</p></div><div><h3>Results</h3><p>There was a lack of knowledge and awareness of HBV infection and transmission and prevention amongst CAB members, also reported among community members and healthcare workers. The participants recognised liver disease symptoms. Perceived causes of liver disease reported by the CAB were alcohol and non-adherence to HIV treatment. Barriers to care included stigma, poverty, and delays in referrals for HBV diagnosis and management.</p></div><div><h3>Conclusion</h3><p>Understanding barriers to care is important to shape future services for diagnosis, treatment and prevention of HBV and liver disease which are accessible, affordable and acceptable to the local population. Education, awareness and advocacy for improved liver health care pathways are required to make them effective for local communities.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 2","pages":"Article 100378"},"PeriodicalIF":5.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000153/pdfft?md5=753eb610beaf8a98f2cb558a403c7fcf&pid=1-s2.0-S2055664024000153-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141394954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identifying patterns of sexual behaviors and PrEP uptake characteristics among MSM who were eligible for PrEP: A national cross-section study","authors":"Yuanyuan Liu ,&nbsp;Xuan Liu ,&nbsp;Siyue Wei ,&nbsp;Zhaoyu Cheng ,&nbsp;Yidan Xian ,&nbsp;Yicheng Zhao ,&nbsp;Jun Ma ,&nbsp;Jiageng Chen ,&nbsp;Zhongdan Chen ,&nbsp;Jie Yang ,&nbsp;Fengli Liu ,&nbsp;Maohe Yu ,&nbsp;Zhuang Cui ,&nbsp;Changping Li","doi":"10.1016/j.jve.2024.100382","DOIUrl":"https://doi.org/10.1016/j.jve.2024.100382","url":null,"abstract":"<div><p>Men who have sex with men (MSM) are at a high risk of HIV infection and should be offered effective preventive measures, such as pre-exposure prophylaxis (PrEP). However, PrEP uptake among eligible MSM was not as high as desired. Diverse research findings on how risky sexual behaviors affect PrEP uptake highlight the necessity for a comprehensive investigation. Understanding the interconnectedness of different sexual behaviors is crucial for evaluating their impact on PrEP uptake among eligible MSM.</p><p>Using a proportional sampling method, we recruited 5877 MSM aged 16 years and above in mainland China according to PrEP eligibility criteria. Through latent class analysis (LCA), three distinct sexual behavior patterns were identified among eligible MSM. Demographic variances and PrEP uptake among the three distinct sexual behavior patterns were examined using chi-squared tests and multinomial logistic regression.</p><p>LCA revealed three patterns: low-risk (4,815 MSM), medium-risk (516 MSM), and high-risk (546 MSM). MSM aged 25 years or older with a monthly income of ≥¥8,000 were more likely to be in the medium-risk group. Those from areas with high HIV prevalence and engaging as \"top\" in anal sex were more likely to be in the medium- and high-risk groups. The medium- and high-risk groups had a higher willingness, uptake, and adherence rates for PrEP than the low-risk group.</p><p>LCA is effective in identifying diverse sexual behavior patterns among MSM, aiding targeted interventions to enhance PrEP uptake. Addressing demographic variations and tailoring interventions for specific risk groups are crucial for promoting PrEP dissemination and reducing HIV infection risk in eligible MSM.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 2","pages":"Article 100382"},"PeriodicalIF":3.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000190/pdfft?md5=1a60e545a08bd146cb85b0179964d886&pid=1-s2.0-S2055664024000190-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141444349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors associated with unquantifiable total HIV-1 DNA in peripheral blood in persons living with HIV: An observational study","authors":"Aurélie Ram ,&nbsp;Vanessa Rascon Velasco ,&nbsp;Gilbert Mchantaf ,&nbsp;Véronique Avettand-Fénoël ,&nbsp;Jean-Paul Viard","doi":"10.1016/j.jve.2024.100370","DOIUrl":"https://doi.org/10.1016/j.jve.2024.100370","url":null,"abstract":"<div><h3>Background</h3><p>The human immunodeficiency virus type 1 (HIV-1) cannot be eradicated even with suppressive antiretroviral therapy because its retrotranscribed genome integrates into the DNA of host cells, creating a long-term reservoir. Quantification of total HIV-1 DNA in peripheral blood is a biomarker of this reservoir that can predict progression of the infection, treatment response, and HIV-1-related complications. A deeper understanding of the reservoir may help develop a cures.</p></div><div><h3>Objective</h3><p>This study aimed to characterize persons living with HIV-1 (PLWH) with unquantifiable total HIV-1 DNA in blood (below the quantification threshold) and identify associated factors.</p></div><div><h3>Methods</h3><p>We have conducted a retrospective observational study. During the study period, all PLWH who had total leukocyte-associated HIV-1 DNA measured by quantitative PCR were included. We have isolated a population of participants with HIV-1 DNA levels below the quantification threshold (40 copies/10⁶ leukocytes).</p></div><div><h3>Results</h3><p>Out of 1094 patients analysed, 62 had unquantifiable and 1032 quantifiable HIV-1 DNA levels in blood. We have found that those with unquantifiable HIV-1 DNA had a higher CD4 T cell nadir (p = 0.006) and a lower viral load zenith (p &lt; 0.001). Multivariate analyses showed that initiation of treatment in primary infection was the only protective factor against HIV-1 DNA quantifiability, the odds of HIV-1 DNA quantifiability decreased by 82% in those treated within 30 days of infection, after controlling for other factors.</p></div><div><h3>Conclusion</h3><p>Our research highlights the importance of an early start of anti-retroviral therapy to limit the size of the HIV-1 reservoir, as receiving treatment during primary infection was found as the only protective factor against quantifiability of HIV-1 DNA in blood.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 1","pages":"Article 100370"},"PeriodicalIF":5.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000074/pdfft?md5=85475b20495f9a09b83dced3f41b8dd3&pid=1-s2.0-S2055664024000074-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140351333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Editorial JVE 10.1","authors":"","doi":"10.1016/j.jve.2024.100373","DOIUrl":"https://doi.org/10.1016/j.jve.2024.100373","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 1","pages":"Article 100373"},"PeriodicalIF":5.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000104/pdfft?md5=58e0f6fb7f27b3cd7e09be833d758335&pid=1-s2.0-S2055664024000104-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140605835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa","authors":"Aude Christelle Ka'e ,&nbsp;Maria Mercedes Santoro ,&nbsp;Leonardo Duca ,&nbsp;Collins Ambe Chenwi ,&nbsp;Ezechiel Ngoufack Jagni Semengue ,&nbsp;Alex Durand Nka ,&nbsp;Naomi-Karell Etame ,&nbsp;Willy Leroi Togna Pabo ,&nbsp;Grace Beloumou ,&nbsp;Marie Laure Mpouel ,&nbsp;Sandrine Djupsa ,&nbsp;Desire Takou ,&nbsp;Samuel Martin Sosso ,&nbsp;Hyppolite K. Tchidjou ,&nbsp;Vittorio Colizzi ,&nbsp;Gregory-Edie Halle-Ekane ,&nbsp;Carlo-Federico Perno ,&nbsp;Sharon Lewin ,&nbsp;R Brad Jones ,&nbsp;Caroline T. Tiemessen ,&nbsp;Joseph Fokam","doi":"10.1016/j.jve.2024.100367","DOIUrl":"https://doi.org/10.1016/j.jve.2024.100367","url":null,"abstract":"<div><h3>Background</h3><p>With the advent of antiretroviral therapy (ART), most children living with HIV in sub-Saharan Africa (SSA) are growing toward adolescence, with scarcity of evidence on the size of viral reservoirs to enhance paediatric cure research strategies. This study aims to compare HIV-1 proviral DNA levels according to virological response among adolescents living with perinatally acquired HIV-1 (ALPHIV) and identify associated-factors in the Cameroonian context.</p></div><div><h3>Methods</h3><p>In this observational cohort study, HIV-1 RNA viremia and CD4⁺ T-cell count were assessed through RT-PCR and flow cytometry respectively at three time-points over 18 months of observation. At the third time-point, 80 randomly-selected participants were classified as with viremia (≥50 HIV-1 copies/mL; n = 40) or without viremia (&lt;50 HIV-1 copies/mL; n = 40); immune-competent (≥500 CD4⁺ T cells/mm³) or immunocompromised (&lt;500 CD4⁺ T cells/mm³). Among these participants, total HIV-1 DNA load was quantified through droplet digital PCR using Bio-Rad QX200.</p></div><div><h3>Results</h3><p>Of the 80 randomly-selected adolescents, median [IQR] age was 15 (13-17) years, 56.2% were female, duration on ART was 9.3 [5.4–12.2] years. Among the 40 viremic ones (median viremia 7312 [283–71482]) HIV-1 copies/ml, 75.0% (30/40) were in virological failure (≥1000 HIV-1 copies/ml), while median of CD4 T cells were 494 [360–793] cell/mm³ with 48.8% (39/80) immunocompromised. No significant variation in HIV-1 RNA viremia and CD4 T cell count was observed between the three time-points, and 13.7% (11/80) adolescents remained aviremic and immune-competent throughout (stable adolescents). A positive and moderate correlation (r = 0.59; p &lt; 0.001) was found between HIV-1 DNA levels and HIV- 1 RNA viremia. Regarding the CD4 T cell count, a negative and weak correlation (r = −0.28; p = 0.014) was found with HIV-1 DNA loads only among adolescents with viremia. Starting ART within the first year of life, ART for over 9 years and aviremia appear as predictors of low HIV-1 DNA loads.</p></div><div><h3>Conclusion</h3><p>Among ALPHIV, high HIV-1 RNA indicates an elevated viral reservoir size, representing a drawback to cure research. Interestingly, early ART initiation and longer ARTduration lead to sustained viral control and limited HIV-1 reservoir size. As limited size of viral reservoir appears consistent with viral control and immune competence, adolescents with sustained viral control (about 14% of this target population) would be candidates for analytical ART interruptions toward establishing paediatric post-treatment controllers in SSA.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 1","pages":"Article 100367"},"PeriodicalIF":5.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000049/pdfft?md5=7d7972636617a72a1c03a870a41e5240&pid=1-s2.0-S2055664024000049-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140351331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Study on immune persistence of the CTN-1V strain rabies vaccine in humans","authors":"Lidong Wang ,&nbsp;Jia Li ,&nbsp;Qiuyue Mu ,&nbsp;Lei Zhu ,&nbsp;Yunpeng Wang ,&nbsp;Ying Sheng ,&nbsp;Danhua Zhao ,&nbsp;Guoling Yang ,&nbsp;Xiaoqing Yu ,&nbsp;Xiaohong Wu ,&nbsp;Li Miao","doi":"10.1016/j.jve.2024.100365","DOIUrl":"10.1016/j.jve.2024.100365","url":null,"abstract":"<div><p>This study is a single-arm, single-center phase IV clinical trial on a rabies vaccine that has been marketed in China. The Vero cells and CTN-1V strain are used in the rabies vaccine product. The purpose of this study was to investigate the safety, immunogenicity and immune persistence of this product. One hundred and forty-nine participants were enrolled to the study, all of whom were included in the safety analysis set (SS), among which 116 participants were included in the protocol analysis set (PPS), One hundred and fifteen participants were included in the 6-month immune persistence analysis set (IPS6) and 111 in the 12-month immune persistence analysis set IPS12. Results showed that: 1) In the SS analysis set, adverse reactions were mainly pyrexia and pain at the vaccination site, the severity of which were mostly grade 1, and concentrated in 0–3 days after vaccination. No grade 3 or above adverse events and serious adverse events (SAE) related to the experimental vaccine were observed. 2) In the PPS analysis set, the antibody positive conversion rate reached 100% at 14 days after full immunization of the pre-immunized negative population; The antibody geometric mean titer (GMT) (95% CI) was 14.82 (13.00, 16.90). 3) The positive rate of serum neutralizing antibody was 93.91 % and the GMT at 1.58 IU/ml at 6 months after full immunization. The positive rate of neutralizing antibody was 85.59 % and GMT at 1.30 IU/ml at 12 months after immunization. Our results show that the human rabies vaccine with the CTN-1V strain and Vero cells as matrix had good safety, immunogenicity and immune persistence in our study.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 1","pages":"Article 100365"},"PeriodicalIF":5.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000025/pdfft?md5=f87ce28507607ca9917c39d334f512bb&pid=1-s2.0-S2055664024000025-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140070871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country","authors":"Erwin Ho ,&nbsp;Axelle Vanderlinden ,&nbsp;Liesbeth Govaerts ,&nbsp;Bo De Fooz ,&nbsp;Pierre Van Damme ,&nbsp;Peter Michielsen ,&nbsp;Thomas Vanwolleghem","doi":"10.1016/j.jve.2024.100369","DOIUrl":"https://doi.org/10.1016/j.jve.2024.100369","url":null,"abstract":"<div><h3>Background and aims</h3><p>In low endemic countries, screening for hepatitis B surface antigen (HBsAg) in migrants is cost-effective in reducing the disease burden of hepatitis B virus (HBV) infections, but linkage to care (LTC) remains a challenge. This study aims to guide future screening initiatives, with 3 objectives: 1. to compare LTC between different ethnic groups screened for HBsAg with point-of-care testing (POCT) in an outreach setting; 2. to estimate the proportion of HBsAg seropositivity for ethnic minorities; and 3. to investigate the association between seropositivity and HBV risk factors.</p></div><div><h3>Methods</h3><p>Opportunistic outreach screenings using finger prick HBsAg tests were performed at civic integration programmes between 11/2017 and 09/2022. If an individual tested positive, an appointment was given immediately at the outpatient hepatology clinic for follow-up and confirmation of HBsAg positivity in blood. Dedicated personnel contacted these individuals to motivate them for further LTC, which was defined as being assessed by a hepatologist, a blood test and an abdominal ultrasound.</p></div><div><h3>Results</h3><p>A total of 677 people from different ethnicities (Asian, Middle Eastern and African) were serologically screened using POCT. The observed positivity for HBsAg was 3.4 % (95% CI 2.17-5.05, 23/677). Apart from ethnicity and male sex, none of the surveyed HBV risk factors were associated with HBsAg seropositivity. All HBsAg positive individuals were linked to care and assessed by a hepatologist, despite the COVID-19 pandemic increase in time to follow-up of 82 days (95% CI 51–112 days) vs. 24 days (95% CI 5–43 days, p = 0.008)).</p><p>Among HBV-infected patients, 31.8% (7/22), 100 % (22/22) and 26.1% (6/23) met the criteria for treatment indication, intrafamilial transmission risk and need for hepatocellular carcinoma surveillance, respectively.</p></div><div><h3>Conclusion</h3><p>The proportion of HBsAg seropositivity in ethnic minorities was 3.4%. POCT and commitment of dedicated personnel can overcome previously identified barriers resulting in a 100% LTC.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 1","pages":"Article 100369"},"PeriodicalIF":5.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000062/pdfft?md5=e69d5e89dd5dfd42292132924c1e3e52&pid=1-s2.0-S2055664024000062-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140351332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}